These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6149809)

  • 1. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
    Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
    Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
    Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 7. The new beta-adrenergic antagonists.
    Chung DC; Laschuk MJ
    Can Anaesth Soc J; 1984 Jul; 31(4):430-3. PubMed ID: 6146393
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
    Porotikov VI; Cherenshchikova EA; Filippov AK; Mashkovskiĭ MD; Iuzhakov SD
    Biull Eksp Biol Med; 1984 Jun; 97(6):677-9. PubMed ID: 6146358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 18. Arrhythmogenic effect of beta-adrenoceptor-blocking drugs in Purkinje fibres of guinea-pig hearts.
    Lemmens-Gruber R; Zilberszac A; Heistracher P
    Arch Int Pharmacodyn Ther; 1996; 331(1):46-58. PubMed ID: 8896710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.